Future Health GCC Stem Cell Bank has attained the distinguished AABB accreditation, marking a significant advancement in regional healthcare standards. This recognition represents one of the most internationally respected benchmarks for quality assurance, safety protocols, and operational excellence within stem cell processing, preservation, and distribution services.
The accreditation followed an exhaustive independent evaluation process that scrutinized the organization’s laboratory operations, quality management frameworks, technical competencies, and regulatory adherence. This achievement substantially enhances Future Health GCC’s credibility among families, medical professionals, and research institutions throughout the Gulf region, demonstrating its dedication to maintaining globally established standards.
Future Health laboratories now possess multiple international certifications including recognition from the Human Tissue Authority, Medicines and Healthcare products Regulatory Agency (MHRA), Swiss Medic, OFSP, and ISO 9001. The addition of AABB accreditation solidifies the facility’s position as one of the region’s most comprehensively accredited stem cell banks, offering unprecedented assurance regarding the long-term security, integrity, and traceability of preserved stem cell specimens.
Chief Executive Officer Ahmad Alahmad emphasized the accomplishment’s significance: “Securing AABB accreditation constitutes a pivotal milestone for Future Health GCC. Combined with our ISO certifications and GMP-grade laboratory infrastructure, this achievement establishes our facility among the region’s most rigorously accredited stem cell centers, underscoring our steadfast dedication to quality, safety, and scientific excellence for families and healthcare collaborators in regenerative medicine.”
This latest accreditation complements Future Health GCC’s sophisticated infrastructure, GMP-grade laboratory facilities, and ongoing investments in technological innovation and specialized expertise. These collective strengths support the organization’s enduring mission to advance regenerative medicine and cellular science while consistently surpassing international standards and stakeholder expectations.
Established in 2005, Future Health GCC manages the UAE’s largest cryogenic stem cell storage facility and maintains cutting-edge, GMP-grade laboratories engineered to support both contemporary and emerging applications in regenerative medicine and cellular therapies. The organization remains committed to expanding its capabilities in alignment with global scientific progress, guided by robust governance protocols, transparency measures, and an enduring commitment to excellence.